Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mesoblast Ltd ADR
(NQ:
MESO
)
6.420
-0.140 (-2.13%)
Streaming Delayed Price
Updated: 2:17 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mesoblast Ltd ADR
< Previous
1
2
3
4
5
6
Next >
Analyst Expectations for Mesoblast's Future
September 21, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 13, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via
InvestorPlace
Analyst Bullish On Cell Therapy Player Mesoblast, But Cuts Price Target
August 31, 2023
Wednesday, Mesoblast Ltd (NASDAQ: MESO) FY23 results, with revenues of $7.5 million for FY2023, compared to $10.2 million in FY2022,
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
August 31, 2023
Via
Benzinga
Why Shares of Mesoblast Are Down Monday
August 07, 2023
The company's shares continued to tumble after it received a Complete Response Letter last week from the FDA.
Via
The Motley Fool
Why Shares of Mesoblast Are Plunging Friday
August 04, 2023
The company received a Complete Response Letter from the FDA regarding its prospective graft-versus-host disease therapy.
Via
The Motley Fool
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 31, 2023
Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer...
Via
Benzinga
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 22, 2023
Via
Benzinga
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 07, 2023
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
August 07, 2023
Via
Benzinga
Dow Turns Lower; Amazon Shares Jump After Strong Q2 Results
August 04, 2023
U.S. stocks pared gains toward the end of trading, with the Dow Jones and S&P 500 turning lower on Friday. The Dow traded down 0.08% to 35,187.47 while the NASDAQ rose 0.18% to 13,984.31. The S&P 500,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 04, 2023
On Friday, 73 companies reached new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 04, 2023
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Nasdaq Surges Over 100 Points; Apple Shares Fall After Q3 Results
August 04, 2023
U.S. stocks were higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. The Dow traded up 0.50% to 35,390.90 while the NASDAQ rose 0.81% to 14,072.42. The S&P 500,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
August 04, 2023
Via
Benzinga
Nikola's Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast's Cell Therapy For Kids: Today's Top Stories
August 04, 2023
Wall Street Journal
Via
Benzinga
Dow Jumps Over 100 Points; US Nonfarm Payrolls Miss Expectations
August 04, 2023
U.S. stocks were higher this morning, following the release of jobs data. Following the market opening Friday, the Dow traded up 0.39% to 35,351.48 while the NASDAQ rose 0.79% to 14,070.50. The S&P...
Via
Benzinga
Mesoblast Shares Tumble As FDA Strikes Out Cell Therapy Application For Children Again, Requires Additional Trial
August 04, 2023
The FDA issued a complete response letter to Mesoblast Limited's (NASDAQ: MESO) resubmission for remestemcel-L for pediatric steroid-refractory acute graft
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 28, 2023
Via
Benzinga
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion
July 27, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 18, 2023
Via
Benzinga
Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday
July 13, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to...
Via
Benzinga
WD-40, Shutterstock And Other Big Stocks Moving Higher On Tuesday
July 11, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Hesai Group (NASDAQ: HSAI) rose 14.4% to $12.34.
Via
Benzinga
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
July 06, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb
Via
Benzinga
William Blair Initiates Mesoblast Soon After Its Lead Product Goes Under FDA Review In Pediatric Indication
March 09, 2023
Via
Benzinga
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 08, 2023
Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.